North America

AI Improved Sepsis Compliance. Patients Still Need the Outcome Proof.

Cancer Progress Still Depends on Your Postcode

MS Has Learnt to Stop Inflammation. It Still Cannot Repair the Damage.

A Boot-Camp Flu Outbreak Put Pentagon Vaccine Policy to the Test.

Resistant hypertension may need a diagnostic revolution, not just another drug

When diabetes tech fails, personalised care fails with it

For Drug-Resistant Epilepsy, Surgery Should Not Be the Only Door

Heart pumps save lives. FDA’s latest Impella alerts show why cardiac device safety cannot stop at approval.
Type 1 diabetes has a kidney problem. FDA is now fast-tracking a possible answer.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
